论文部分内容阅读
目的评价对已经行直接经皮冠状动脉介入治疗(PCI)的非ST段抬高型急性冠脉综合征(NSTEACS)患者专人定期随诊的远期疗效,探讨NSTEACS患者就医行为和临床预后的相关性.方法2010年10月1日至2011年9月30日临床确诊为NSTEACS,并成功接受直接PCI术的患者463例,其中男364例,女99例.接受定期专人随诊的患者归入规范组(n=255),未定期非专人随诊患者非规范组(n=208).分别比较两组1年死亡率、再住院率.结果规范组患者的1年累计主要心血管事件(MACE)发生率、靶血管重建率、再住院率分别为2.75%、1.57%、3.53%,明显低于非规范组的3.85%、2.40%、5.77%.结论接受了直接PCI术的急性冠脉综合征(ACS)患者,在经过专人定期随诊后,其1年内MACE发生率、靶血管重建率、再住院率可得到明显降低.加强定期专人NATEACS患者的随诊是改善ACS患者预后的重要措施.“,”Objective To understand and compare the clinical effect and cost-effective ratio in patients with Non-ST-segment elevation acute coronary syndrome (NSTEACS) who accepted primary PCI. Methods There were 463 patients with NSTEACS patients accepted primary PCI in the study, including 364 males and 99 females. All patients were told that they should accept specialized follow-up among one year. They were divided into the standardized group (n = 255) and the non-standardized group (n = 208) by patients whether or not accepting specialized treat and follow-up. Results The rate of major adverse cardiovascular events (MACE), target vessel revascularization and re-hospitalization in standardization group were better than that in non-standardization group (2.75%, 1.57%, 3.53% VS 3.85%, 2.40%, 5.77%). Conclusion The rate of MACE, target vessel revascularization and re-hospitalization were decreased signifcantly in the standardized group than that in non-standardized group. The prognoses of patients with NSTEACS accepted primary PCI were greatly improved by supervising medical behavior and intensifying the specialized treatment and follow-up by schedule.